NEE
44
2
HCA
48
4
FITB
58
-2
STX
56
-3
CHRW
50
2
CHK
39
4
JNPR
60
-2
GPS
59
4
LUV
62
3
DGX
36
8
REGN
62
-3
SEE
36
3
HBI
45
-3
LLY
62
-6
STZ
60
-4
AON
39
-2
SWN
59
3
SYF
79
-2
NDAQ
55
2
NVDA
60
4
NEE
44
2
HCA
48
4
FITB
58
-2
STX
56
-3
CHRW
50
2
CHK
39
4
JNPR
60
-2
GPS
59
4
LUV
62
3
DGX
36
8
REGN
62
-3
SEE
36
3
HBI
45
-3
LLY
62
-6
STZ
60
-4
AON
39
-2
SWN
59
3
SYF
79
-2
NDAQ
55
2
NVDA
60
4
Financhill
Back

SunCoke Energy 10K Form

Buy
78

SXC
SunCoke Energy

Last Price:
10.22
Seasonality Move:
-1.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SXC News And Ratings

See the #1 stock for the next 7 days that we like better than SXC

SXC Financial Statistics

Sales & Book Value

Annual Sales: $2.06B
Cash Flow: $-5.5M
Price / Cash Flow: 6.87
Annual Sales: $7.41
Price / Book: 1.38

Profitability

EPS (TTM): 0.71000
Net Income (TTM): $61.2M
Gross Margin: $338.6M
Return on Equity: 9.53%
Return on Assets: 3.68%

SunCoke Energy Earnings Forecast

Key SunCoke Energy Financial Ratios

  • The Gross Profit Margin over the past 15 years for SXC is 16.41%.
  • The Selling, General & Administrative Expenses for SXC have been equal to 3.43% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 47.48% of Operating Income.
  • The Net Earning history of SXC is 2.79% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

SunCoke Energy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Metals & Mining
Sector: Materials
Current Symbol: SXC
CUSIP: 86722A
Website: suncoke.com

Debt

Debt-to-Equity Ratio: 0.79
Current Ratio: 2.06
Quick Ratio: 1.1

Price-to-Earnings

Trailing P/E Ratio: 15.04
Forward P/E Ratio: 14.41

SXC Technical Analysis vs Fundamental Analysis

Buy
78
SunCoke Energy (SXC) is a Buy

Is SunCoke Energy a Buy or a Sell?

  • SunCoke Energy stock is rated a Buy
    The current SunCoke Energy [SXC] share price is $10.23. The Score for SXC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.